Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer

Susan M. Domchek; Gillian Mitchell; Geoffrey J. Lindeman; Nadine M. Tung; Judith Balmana; Steven J. Isakoff; Rita Schmutzler; M. William Audeh; Niklas Loman; Clare Scott; Michael Friedlander; Bella Kaufman; Judy E. Garber; Andrew Tutt; Mark E. Robson

doi:10.1200/JCO.2011.36.8134

Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer

Susan M. Domchek, Gillian Mitchell, Geoffrey J. Lindeman, Nadine M. Tung, Judith Balmana, Steven J. Isakoff, Rita Schmutzler, M. William Audeh, Niklas Loman, Clare Scott, Michael Friedlander, Bella Kaufman, Judy E. Garber, Andrew Tutt, Mark E. Robson

Breastcancer-genetics

Research output: Contribution to journal › Debate/Note/Editorial

Original language	English
Pages (from-to)	4224-4226
Journal	Journal of Clinical Oncology
Volume	29
Issue number	32
DOIs	https://doi.org/10.1200/JCO.2011.36.8134
Publication status	Published - 2011

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2011.36.8134

Cite this

Domchek, S. M., Mitchell, G., Lindeman, G. J., Tung, N. M., Balmana, J., Isakoff, S. J., Schmutzler, R., Audeh, M. W., Loman, N., Scott, C., Friedlander, M., Kaufman, B., Garber, J. E., Tutt, A., & Robson, M. E. (2011). Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer. Journal of Clinical Oncology, 29(32), 4224-4226. https://doi.org/10.1200/JCO.2011.36.8134

@article{2a18395be02349969a54c6b84f7520d7,

title = "Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer",

author = "Domchek, {Susan M.} and Gillian Mitchell and Lindeman, {Geoffrey J.} and Tung, {Nadine M.} and Judith Balmana and Isakoff, {Steven J.} and Rita Schmutzler and Audeh, {M. William} and Niklas Loman and Clare Scott and Michael Friedlander and Bella Kaufman and Garber, {Judy E.} and Andrew Tutt and Robson, {Mark E.}",

year = "2011",

doi = "10.1200/JCO.2011.36.8134",

language = "English",

volume = "29",

pages = "4224--4226",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "Lippincott Williams & Wilkins",

number = "32",

}

Domchek, SM, Mitchell, G, Lindeman, GJ, Tung, NM, Balmana, J, Isakoff, SJ, Schmutzler, R, Audeh, MW, Loman, N, Scott, C, Friedlander, M, Kaufman, B, Garber, JE, Tutt, A & Robson, ME 2011, 'Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer', Journal of Clinical Oncology, vol. 29, no. 32, pp. 4224-4226. https://doi.org/10.1200/JCO.2011.36.8134

TY - JOUR

T1 - Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer

AU - Domchek, Susan M.

AU - Mitchell, Gillian

AU - Lindeman, Geoffrey J.

AU - Tung, Nadine M.

AU - Balmana, Judith

AU - Isakoff, Steven J.

AU - Schmutzler, Rita

AU - Audeh, M. William

AU - Loman, Niklas

AU - Scott, Clare

AU - Friedlander, Michael

AU - Kaufman, Bella

AU - Garber, Judy E.

AU - Tutt, Andrew

AU - Robson, Mark E.

PY - 2011

Y1 - 2011

U2 - 10.1200/JCO.2011.36.8134

DO - 10.1200/JCO.2011.36.8134

M3 - Debate/Note/Editorial

C2 - 21931031

SN - 1527-7755

VL - 29

SP - 4224

EP - 4226

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 32

ER -